CIK 0001672688 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Absci Corp
Sign in to watch- Ticker
- ABSI
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 853383487
- Phone
- (360) 949-1041
- Business address
- 18105 SE MILL PLAIN BLVD, VANCOUVER, WA, 98683
- Former names
- AbSci, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 40 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-29 | McClain Sean Chief Executive Officer | Shares withheld for taxes | −79,860 | $12.10 | $966K | 8,552,402 |
| 2026-10-12 | McClain Sean Chief Executive Officer | Shares withheld for taxes | −23,293 | $10.16 | $237K | 8,632,262 |
| 2026-10-12 | Bedrick Todd SVP, CAO | Shares withheld for taxes | −22,325 | $10.16 | $227K | 199,128 |
| 2026-10-12 | Jonasson Zachariah CFO / CBO | Shares withheld for taxes | −387 | $10.16 | $4K | 484,918 |
| 2026-08-31 | Jonasson Zachariah CFO / CBO | Shares withheld for taxes | −8,320 | $8.71 | $72K | 483,144 |
| 2026-08-03 | Somaratne Ransi Mudalinayake CMO, Head of R&D | Grant or award · Stock Option (right to buy) | +383,000 | 383,000 | ||
| 2026-06-30 | Szela Mary T Director | Purchase | +12,900 | $11.54 | $149K | 21,300 |
| 2026-06-24 | McClain Sean Chief Executive Officer | Shares withheld for taxes | −59,896 | $10.08 | $603K | 8,655,555 |
| 2026-06-04 | Szela Mary T Director | Grant or award | +8,400 | 8,400 | ||
| 2026-06-04 | Szela Mary T Director | Grant or award · Stock Option (right to buy) | +33,200 | 33,200 | ||
| 2026-06-04 | MCGINNIS KAREN K Director | Grant or award | +10,100 | 48,420 | ||
| 2026-06-04 | MCGINNIS KAREN K Director | Grant or award · Stock Option (right to buy) | +39,800 | 39,800 | ||
| 2026-06-04 | Pangalos Menelas N Director | Grant or award | +10,100 | 242,408 | ||
| 2026-06-04 | Pangalos Menelas N Director | Grant or award · Stock Option (right to buy) | +39,800 | 39,800 | ||
| 2026-06-04 | VAN HOUTEN FRANS Director | Grant or award | +10,100 | 73,420 | ||
| 2026-06-04 | VAN HOUTEN FRANS Director | Grant or award · Stock Option (right to buy) | +39,800 | 39,800 | ||
| 2026-06-04 | Rabinovitsj Daniel A Director | Grant or award | +10,100 | 33,420 | ||
| 2026-06-04 | Rabinovitsj Daniel A Director | Grant or award · Stock Option (right to buy) | +39,800 | 39,800 | ||
| 2026-06-04 | Sirosh Joseph Director | Grant or award | +10,100 | 33,420 | ||
| 2026-06-04 | Sirosh Joseph Director | Grant or award · Stock Option (right to buy) | +39,800 | 39,800 |
Page 1 of 8 · 154 trades